Liver Transplant Articles & Analysis: Older
9 articles found
There is currently no cure for biliary tract diseases other than liver transplantation, so new modalities of treatment are urgently needed. ...
Manifestation of clustered clinical conditions in MetS is one of the leading causes of liver steatosis, which is confirmed by recurrence of non-alcoholic fatty liver disease in patients with MetS after liver transplantation (19). ...
Nonalcoholic fatty liver disease (NAFLD) is associated with obesity but also found in non-obese individuals. ...
Increases sepsis compliance by 20% in under 30 days in high-performing organziations and even more in low-performing ones Provides analytics and tools to automate the processes needed to treat sepsis on time Delivers at-a-glance situational awareness Allows for a tele-sepsis model and outsourcing Is the ONLY FDA Class II cleared sepsis solution on the market CASE STUDY KEVIN ...
The Problem: When Kevin Kronmiller was 22, he found out he had 5 years to live if he didn't receive a liver transplant. Beating the odds, Kevin made it to 50 before needing a liver transplant. ...
Publication Summary: Nonalcoholic fatty liver disease (NAFLD) is a chronic condition that originates as lipid accumulation within hepatocytes (steatosis) and progresses into nonalcoholic steatohepatitis (NASH), characterized by lipid accumulation, inflammation, oxidative stress, and fibrosis. NAFLD is now recognized as the most common cause of chronic liver ...
These diseases are caused by a genetic defect that results in either too little or no production of a critical metabolic enzyme produced by liver cells, leading to recurring, life-threatening metabolic events as the patient’s blood becomes highly acidic. Typically impacting young children, these events cause devastating long-term impairments – and currently the only ...
Publication Summary: Nonalcoholic fatty liver disease (NAFLD) is a chronic condition that originates as lipid accumulation within hepatocytes (steatosis) and progresses into nonalcoholic steatohepatitis (NASH), characterized by lipid accumulation, inflammation, oxidative stress, and fibrosis. NAFLD is now recognized as the most common cause of chronic liver ...
Although Liver Transplantation (LT) has become standard procedure for hepatic failure patients, a number of issues still need to be addressed which make LT a very challenging field. One alternative way for liver failure therapy is a bioartificial liver (BAL) (hepatocytes cells device). ...